-
The overall goal of HOPA's education program is to equip oncology pharmacy practitioners with knowledge about current developments and to improve the efficiency of healthcare delivery while maintaining or exceeding the quality of patient care.
-
In addition to the flagship HOPA Annual Conference, HOPA presents regional conference programming across the country that offer a variety of in-depth clinical education, practice management, and BCOP Recertification offerings.
-
Welcome to the all-new HOPA Resources where we consider all searches “advanced searches.”
-
The HOPA Health Policy and Advocacy committee is dedicated to acting as an advocate on behalf of patients as well as representing hematology/oncology pharmacists across the country in legislative and regulatory endeavors.
Membership
HOPA is an active and engaged organization that provides crucial education, networking, cutting edge resources and advancement opportunities to our members. Find yourself in HOPA.
Join or renew your membership today!HOPA and Medscape Oncology Education
HOPA has teamed up with Medscape Oncology Education to provide a series of educational activities designed for pharmacists who specialize in hematology/oncology as well as those who practice in a broader setting and care for patients with cancer less frequently. The collaboration is called Pharmacist Focus on Oncology.
Learn moreDrug Updates
-
Sacituzumab govitecan (TRODELVY, Immunomedics Inc.) – all entries with PAPs
Sacituzumab govitecan-hziy (TRODELVY, Immunomedics, Inc.), for metastatic triple negative breast cancer....
-
Pemigatinib (PEMAZYRE, Incyte Corporation) – all entries with PAPs
Pemigatinib (PEMAZYRE, Incyte Corporation) for adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with fibroblast...
-
Tucatanib (TUKYSA, Seattle Genetics, Inc.)
Tucatanib (TUKYSA, Seattle Genetics, Inc.) , for patients with HER2-positive metastatic breast cancer....
-
Phesgo—a combination of pertuzumab, trastuzumab and hyaluronidase–zzxf
Phesgo—a combination of Pertuzumab, Trastuzumab and Hyaluronidase–zzxf for injection under the skin to treat adult patients with...
Pharmacy Events
HOPA’s BCOP education courses cover the four Domains of Oncology Pharmacy Specialty Practice and improve your knowledge and problem-solving skills in each area. These courses provide BCOP-specific assessments for practicing clinical oncology pharmacists with a need for specific disease prevention and treatment knowledge and strategies.
You can now earn up to 66 hours of BCOP credit through HOPA—the experts in clinical oncology pharmacy. In addition to HOPA’s current BCOP education offerings, HOPA will offer a BCOP Preparatory and Recertification Course being released in 2020. This course is designed for pharmacists preparing to sit for the BCOP Certification Exam as well as those looking to meet the Board of Pharmacy Specialties (BPS) requirement to complete a Preparatory Review/Recertification Course at least once during their recertification cycle. The course will be offering 28 hours of on-demand recertification credit.
Learn More
Latest Discussions
HOPA YouTube
Stay informed on the latest research and treatments with HOPA’s videos; and get an exclusive insight into our organization and its dedicated members. HOPA’s YouTube Channel.
